Skip to content
Disclosery

Cambridge Investment Research Advisors, Inc.: APLE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cambridge Investment Research Advisors, Inc. on APLE, newest first. How the timeline and the estimate are built.

Cambridge Investment Research Advisors, Inc. held 25,174 APLE shares at 2026-06-30 per its 13F-HR/A filed 2026-07-30.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 25,174 shares
    Change vs previous 13F +9,351 shares

    <0.01% of the 13F portfolio, value $423,000.

    13F-HR/A 0001419186-26-000006 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 15,823 shares
    Change vs previous 13F +378 shares

    <0.01% of the 13F portfolio, value $182,000.

    13F-HR 0001419186-26-000003 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 15,445 shares
    Change vs previous 13F -9,711 shares

    <0.01% of the 13F portfolio, value $183,000.

    13F-HR 0001419186-26-000001 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 25,156 shares
    Change vs previous 13F +12,252 shares

    <0.01% of the 13F portfolio, value $302,000.

    13F-HR 0001419186-25-000008 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 12,904 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $151,000.

    13F-HR 0001419186-25-000006 filed by Cambridge Investment Research Advisors, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).